###begin article-title 0
Complement receptor 1 polymorphisms associated with resistance to severe malaria in Kenya
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 50 54 50 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl2 </italic>
###xml 58 61 58 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">McC</italic>
###xml 61 63 61 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b </italic>
###xml 61 63 61 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b </italic></sup>
###xml 211 233 211 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 211 232 <span type="species:ncbi:5833">Plasmodium falciparum</span>
It has been hypothesized that the African alleles Sl2 and McCb of the Swain-Langley (Sl) and McCoy (McC) blood group antigens of the complement receptor 1 (CR1) may confer a survival advantage in the setting of Plasmodium falciparum malaria, but this has not been demonstrated.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 25 33 <span type="species:ncbi:9606">children</span>
To test this hypothesis, children in western Kenya with severe malaria-associated anaemia or cerebral malaria were matched to symptomatic uncomplicated malaria controls by age and gender. Swain-Langley and McCoy blood group alleles were determined by restriction fragment length polymorphism and conditional logistic regression was carried out.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 127 133 127 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl2/2 </italic>
###xml 246 251 246 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl1/1</italic>
###xml 285 294 285 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl2/2 McC</italic>
###xml 294 298 294 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a/b </italic>
###xml 294 298 294 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a/b </italic></sup>
###xml 414 423 414 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl1/1 McC</italic>
###xml 423 426 423 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a/a</italic>
###xml 423 426 423 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a/a</italic></sup>
###xml 113 121 <span type="species:ncbi:9606">children</span>
###xml 232 240 <span type="species:ncbi:9606">children</span>
No significant association was found between the African alleles and severe malaria-associated anaemia. However, children with Sl2/2 genotype were less likely to have cerebral malaria (OR = 0.17, 95% CI 0.04 to 0.72, P = 0.02) than children with Sl1/1. In particular, individuals with Sl2/2 McCa/b genotype were less likely to have cerebral malaria (OR = 0.18, 95% CI 0.04 to 0.77, P = 0.02) than individuals with Sl1/1 McCa/a.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl2 </italic>
###xml 76 79 76 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">McC</italic>
###xml 79 81 79 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b </italic>
###xml 79 81 79 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b </italic></sup>
These results support the hypothesis that the Sl2 allele and, possibly, the McCb allele evolved in the context of malaria transmission and that in certain combinations probably confer a survival advantage on these populations.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 0 22 0 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 145 146 145 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 288 289 288 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 385 386 385 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 387 388 387 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 0 21 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Plasmodium falciparum malaria is responsible for most of the more than one million deaths that occur each year from malaria infection in Africa [1]. Most of these deaths occur as a result of complications such as severe malaria-associated anaemia (SMA) and cerebral malaria (CM) or coma [2]. The pathogenesis of these complications is poorly understood. Evidence from several studies [3-7] suggests that the complement receptor 1 (CR1, CD35) may be involved in the pathogenesis of severe malaria. However, its exact role is not known.
###end p 11
###begin p 12
###xml 28 29 28 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 29 31 29 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r </italic>
###xml 29 31 29 31 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>r </italic></sub>
###xml 277 278 277 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 288 289 288 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 395 396 395 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 397 399 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1030 1044 1030 1044 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 1086 1087 1086 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1088 1089 1088 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1215 1229 1215 1229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 1365 1367 1365 1367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1368 1370 1368 1370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1030 1043 <span type="species:ncbi:5833">P. falciparum</span>
###xml 1215 1228 <span type="species:ncbi:5833">P. falciparum</span>
CR1 is a protein ranging in Mr from 190 to 280 kDa. It is found on erythrocytes and most leukocytes and it is divided into three to four long homologous repeat regions (LHRs) and 27 to 30 short consensus repeats (SCRs), also known as complement control protein repeats (CCPs) [8] (Figure 1). LHR-A binds C4b, whereas LHR-B and C bind both C4b and C3b. LHR-D binds mannan-binding lectin and C1q [9,10]. Together with other erythrocyte complement regulatory proteins such as decay accelerating factor (DAF, CD55) and membrane inhibitor of reactive lysis (MIRL, CD59), CR1 serves to attenuate the complement cascade. Specifically, CR1 promotes the Factor I-mediated inactivation of C3b to C3bi and promotes inactivation of C3 convertases. CR1 on erythrocytes also binds opsonized immune complexes carrying them to organs of the reticuloendothelial system for removal. Altogether, these functions serve to protect erythrocytes and other host cells from complement-mediated damage. In addition, CR1 is thought to be a receptor for the P. falciparum erythrocyte membrane protein 1 (PfEMP-1) [3,4]. The interaction between PfEMP-1 and CR1 may be responsible for rosetting, a phenomenon in which erythrocytes infected with P. falciparum late stage parasites bind to uninfected erythrocytes in vitro and has been associated with cerebral malaria in several African studies [11,12].
###end p 12
###begin p 13
###xml 0 98 0 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Schematic diagram of the most common structural variant of complement receptor 1 (CR1*1, F allele)</bold>
###xml 122 123 122 123 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
Schematic diagram of the most common structural variant of complement receptor 1 (CR1*1, F allele). The amino terminal (NH2) extracellular portion is composed of 30 complement control protein repeats (CCPs; vertical boxes numbered 1-30) arranged into four long homologous regions (LHRs) A-D, each composed of seven CCPs. There are two distinct functional domains each composed of three complement control protein repeats (CCPs) (vertical hatched boxes): site 1 in LHR-A (CCPs 1-3) binds mainly C4b and has convertase decay accelerating activity, and two virtually identical copies of site 2 in LHR-B (CCPs 8-10) and LHR-C (CCPs 15-17) that bind C3b and C4b, as well as PfEMP-1, and possess Factor I- cofactor activity. Functional differences in sites 1 and 2 are determined by amino acid sequence differences. Boxes with the same hatching pattern reflect near amino acid identity of the CCPs. CCP 25 (stippled box) carries the Swain-Langley (Sl) and McCoy (McC) Knops blood group antigens. The CCP repeats are followed by a transmembrane domain (TM) and a cytoplasmic tail (CYT).
###end p 13
###begin p 14
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 191 192 191 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 344 346 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 503 505 503 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 506 508 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
The CR1 gene exhibits a number of polymorphisms. There are several size variants which are felt to be the result of unequal gene crossover [13]. The most common variant has four LHRs (Figure 1). Polymorphisms that correlate with the quantitative expression of CR1 on erythrocytes of Caucasians but not of Africans have also been identified [14,15]. Lastly, the Knops blood group antigens, including the Swain-Langley (Sl), McCoy (McC) and their alleles, have been localized to the CR1 protein in LHR-D [16-18].
###end p 14
###begin p 15
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 529 533 529 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl2 </italic>
###xml 537 540 537 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink">McC</italic>
###xml 540 542 540 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b </italic>
###xml 540 542 540 542 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b </italic></sup>
###xml 737 738 737 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 805 809 805 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl2 </italic>
###xml 812 815 812 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink">McC</italic>
###xml 815 817 815 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b </italic>
###xml 815 817 815 817 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b </italic></sup>
###xml 878 880 878 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1200 1202 1200 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1205 1209 1205 1209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl2 </italic>
The study of the Sl and McC blood group antigens may offer further clues as to the role of CR1 in the pathogenesis of severe malaria. The phenotypic absence of these antigens, designated Sl -1,2 [19] and McC(a-b+) respectively, is occasionally the result of low CR1 copy numbers on the RBC or, most commonly, due to non-synonymous base substitutions [17]. The alleles responsible for the phenotypic absence are very rare in ethnic groups that are not of African descent. Thus, this observation has led to the hypothesis that the Sl2 and McCb alleles may confer a survival advantage in the face of diseases such as malaria. In support of this hypothesis Sl -1,2 erythrocytes were found to rosette less in vitro than Sl 1,-2 erythrocytes [3]. However, a recent study failed to reveal an association between Sl2 or McCb and resistance to severe malaria in The Gambia, West Africa [20]. The present study describes the findings of an investigation designed to determine whether there is an association between resistance or susceptibility to severe malaria and the Sl and McC blood group alleles in western Kenya, a region of malaria endemicity. The findings suggest that, contrary to a previous report [20], Sl2 does confer an advantage in the setting of malaria infection.
###end p 15
###begin title 16
Methods
###end title 16
###begin title 17
Populations and study design
###end title 17
###begin p 18
###xml 470 471 470 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 472 473 472 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 520 534 520 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 1173 1175 1171 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1259 1273 1257 1271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 1352 1354 1348 1350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1738 1752 1732 1746 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 0 12 <span type="species:ncbi:9606">Participants</span>
###xml 34 39 <span type="species:ncbi:9606">human</span>
###xml 70 75 <span type="species:ncbi:9606">Human</span>
###xml 385 397 <span type="species:ncbi:9606">participants</span>
###xml 498 506 <span type="species:ncbi:9606">children</span>
###xml 520 533 <span type="species:ncbi:5833">P. falciparum</span>
###xml 1259 1272 <span type="species:ncbi:5833">P. falciparum</span>
###xml 1738 1751 <span type="species:ncbi:5833">P. falciparum</span>
###xml 1938 1946 <span type="species:ncbi:9606">Children</span>
###xml 2131 2139 <span type="species:ncbi:9606">children</span>
###xml 2400 2408 <span type="species:ncbi:9606">children</span>
Participants were recruited under human use protocols approved by the Human Subjects Research Review Board, Office of the Surgeon General, US Army, and the Ethics Review Committee of the Kenya Medical Research Institute, Nairobi, Kenya. All procedures were in accordance with the Helsinki Declaration. The study had a matched case-control design. The demographics of some of the study participants as well as the inclusion/exclusion criteria have been described before [5-7]. SMA cases, defined as children with asexual P. falciparum parasitaemia by Giemsa-stained thick and thin blood smear and Hb </= 5 g/dL, were recruited from the pediatric ward of the Nyanza Provincial General Hospital (NPGH), Kisumu, Kenya. The NPGH catchment area is the malaria holoendemic region of the Lake Victoria basin in western Kenya, where most individuals are of the Luo ethnic group. Because CM is uncommon in the Lake Victoria basin, CM cases were recruited from the pediatric ward of the Kisii District Hospital (KDH), as well as from the NPGH. KDH is located in the highlands of western Kenya where transmission is seasonal and consequently receives many more CM cases than the NPGH [21]. The predominant ethnic group in Kisii is the Abagusii. CM was defined as asexual P. falciparum parasitaemia by Giemsa-stained blood smear and a Blantyre coma score of </= 2 [22], lasting at least 30 min if there was a history of convulsions. One control with symptomatic uncomplicated malaria was matched to each case by age +/- two months and gender and was identified from the outpatient clinic of the same hospital where the corresponding case was obtained. Symptomatic uncomplicated malaria was defined as a Giemsa-stained blood smear positive for asexual P. falciparum and an axillary temperature >/= 37.5degreesC or, in the absence of the latter, two of the following signs or symptoms: nausea/vomiting, irritability, poor feeding, myalgias or headache. Children were excluded from participation if there was evidence of other concomitant serious infections (i.e. meningitis excluded by lumbar puncture, pneumonia, sepsis) or chronic illness. All children with suspected CM underwent a lumbar puncture to exclude meningitis and were enrolled if the results of Gram stain and culture were negative. In addition, because some of our studies also included the measurement of erythrocyte complement regulatory proteins, children were excluded if they had a history of blood transfusion in the three months preceding enrolment to avoid the influence of donor erythrocytes.
###end p 18
###begin title 19
Genotyping of CR1 Knops blood group polymorphisms
###end title 19
###begin p 20
###xml 566 568 566 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 656 664 650 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl1/Sl2 </italic>
###xml 668 671 662 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">McC</italic>
###xml 671 672 665 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 671 672 665 666 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a</italic></sup>
###xml 673 676 667 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">McC</italic>
###xml 676 678 670 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b </italic>
###xml 676 678 670 672 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b </italic></sup>
###xml 787 789 781 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 827 828 821 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 903 905 897 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1126 1130 1120 1124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CR1 </italic>
###xml 1329 1330 1322 1323 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1392 1396 1383 1385 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 1785 1788 1743 1746 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mfe</italic>
###xml 1847 1850 1805 1808 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl1</italic>
###xml 1851 1854 1809 1812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl2</italic>
###xml 1859 1862 1817 1820 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsm</italic>
###xml 1908 1911 1866 1869 <italic xmlns:xlink="http://www.w3.org/1999/xlink">McC</italic>
###xml 1911 1912 1869 1870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 1911 1912 1869 1870 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a</italic></sup>
###xml 1913 1916 1871 1874 <italic xmlns:xlink="http://www.w3.org/1999/xlink">McC</italic>
###xml 1916 1917 1874 1875 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 1916 1917 1874 1875 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b</italic></sup>
###xml 2019 2021 1977 1979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 225 237 <span type="species:ncbi:9606">participants</span>
A whole blood sample obtained at enrolment, and prior to any blood transfusion, was used to extract DNA and/or blotted onto filter papers for later extraction. Personnel who were unaware of the group assignments of the study participants carried out DNA extraction, amplification and interpretation of restriction fragment length polymorphisms (RFLPs) patterns. DNA was extracted from whole blood using the QIAamp DNA blood extraction protocol (Qiagen, Valencia, CA). DNA extraction from filter papers was performed using saponin and Chelex as previously described [23]. Once extracted, genomic DNA was stored frozen at -20degreesC for later analysis. The Sl1/Sl2 and McCa/McCb Knops blood group alleles result from single nucleotide polymorphisms that cause specific amino acid changes[17] in exon 29 (encoding CCP 25; Figure 1). An established PCR-RFLP method was used for the detection of both SNPs [24]. Briefly, the oligonucleotide forward primer 24KnNde: 5'-ACC AGT GCC ACA CTG GAC CAG ATG GAG AAC AGC TGT TTG AGC AT-3' and reverse primer 25Rb: 5'-GGA GGA GTG TGG CAG CTT G-3', were used to amplify a 305 bp fragment of CR1 exon 29 by PCR. The amplification reactions were carried out on ~500 ng of genomic DNA in a 100 mul final volume containing 1x GeneAmp PCR Buffer II (Applied Biosystems, Foster City, CA), 2.5 mM MgCl2, 200 muM each dNTP, 0.2 muM each primer and 5 U AmpliTaq Gold(R) DNA Polymerase (Applied Biosystems, Foster City, CA). After 9 min of initial denaturation at 95degreesC, the thermocycling program used consisted of 1 min denaturation at 94degreesC, 1 min annealing at 58degreesC, and 1 min extension at 72degreesC for 44 cycles, followed by a final extension of 10 min at 72degreesC. For RFLP analysis, 28 muL of each PCR product was digested with either MfeI (New England Biolabs, Beverly, MA), for the detection of Sl1/Sl2, or BsmI (New England Biolabs), for the detection of McCa/McCb, and the restriction fragments were resolved by agarose gel electrophoresis as previously described [24].
###end p 20
###begin title 21
Statistical analysis
###end title 21
###begin p 22
All analyses were done using SPSS version 11.5 (SPSS Inc., Chicago, IL). Chi-square tests were performed to compare the observed and predicted frequencies of genotypes based on allelic frequencies in different ethnic groups. Conditional logistic regression based on matched pairs and adjusted for ethnic groups was carried out for each single locus (Sl and McC) and for the combination of the two loci. Thus, each regression model included terms both for genotype and ethnic group. All tests were two-sided with alpha = 0.05.
###end p 22
###begin title 23
Results
###end title 23
###begin title 24
Population demographics
###end title 24
###begin p 25
###xml 6 7 6 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
Table 1 describes the total numbers of cases and controls per group and hospital. The cases and controls were well matched in age, gender and ethnic group distribution. Most of the cases and controls recruited from the NPGH were of the Luo ethnic group, whereas most of the cases and controls recruited from the KDH were of the Abagusii ethnic group.
###end p 25
###begin p 26
Group demographics
###end p 26
###begin p 27
Other: Kalenjin (3), Kikuyu (3), Turkana (1), Teso (1), Nandi (1), Bukusu (1)
###end p 27
###begin title 28
Genotype frequencies
###end title 28
###begin p 29
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl2 </italic>
###xml 8 11 8 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">McC</italic>
###xml 11 13 11 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b </italic>
###xml 11 13 11 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b </italic></sup>
###xml 53 55 53 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 64 66 64 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 183 184 183 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
Sl2 and McCb alleles were more common in The Gambia [20], Mali [17] and western Kenya than in other non-African ethnic or racial groups where they occurred in very few numbers (Table 2). There were no significant differences between predicted and observed genotype frequencies for the two major ethnic groups, Luos and Abagusiis (data not shown), suggesting that the genotypes within these populations are in Hardy-Weinberg equilibrium.
###end p 29
###begin p 30
Percent of Swain-Langley and McCoy genotypes in various populations.
###end p 30
###begin title 31
Sl2/2 is associated with decreased susceptibility to cerebral malaria
###end title 31
###begin p 32
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl2 </italic>
###xml 39 42 39 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">McC</italic>
###xml 42 44 42 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b </italic>
###xml 42 44 42 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b </italic></sup>
###xml 122 126 122 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl1 </italic>
###xml 130 133 130 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">McC</italic>
###xml 133 135 133 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a </italic>
###xml 133 135 133 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a </italic></sup>
###xml 240 246 240 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl1/1 </italic>
###xml 249 252 249 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">McC</italic>
###xml 252 256 252 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a/a </italic>
###xml 252 256 252 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a/a </italic></sup>
###xml 276 277 276 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 317 323 317 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl1/2 </italic>
###xml 326 332 326 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl2/2 </italic>
###xml 457 463 457 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl2/2 </italic>
###xml 593 599 593 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl2/2 </italic>
###xml 672 678 672 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl1/1 </italic>
###xml 885 888 885 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink">McC</italic>
###xml 888 892 888 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a/b </italic>
###xml 888 892 888 892 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a/b </italic></sup>
###xml 895 898 895 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink">McC</italic>
###xml 898 902 898 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b/b </italic>
###xml 898 902 898 902 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b/b </italic></sup>
###xml 946 949 946 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl </italic>
In order to explore whether the Sl2 or McCb alleles confer resistance or susceptibility to severe malaria compared to the Sl1 and McCa alleles, conditional logistic regression of the individual genotypes at each locus was carried out using Sl1/1 or McCa/a as reference (Table 3). There was no association between the Sl1/2 or Sl2/2 genotype and resistance or susceptibility to SMA. Although there was a trend towards decreased susceptibility to SMA for the Sl2/2 genotype, the association was not significant (OR = 0.65, 95% CI 0.14 to 3.06, P = 0.59). On the other hand, individuals with the Sl2/2 genotype were less likely to have cerebral malaria than individuals with Sl1/1 (OR = 0.17, 95% CI 0.04 to 0.72, P = 0.02). This finding was independent of the hospital site since inclusion of this variable in the model did not affect the results. There was no significant effect of the McCa/b or McCb/b genotypes, when averaged over the different Sl alleles, on resistance or susceptibility to CM.
###end p 32
###begin p 33
Conditional logistic regression based on matching to compare individual genotypes.
###end p 33
###begin p 34
OR = Odds Ratio, CI = Confidence interval, Ref = Reference Category
###end p 34
###begin title 35
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl2/2 McC</italic>
###xml 9 13 9 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a/b </italic>
###xml 9 13 9 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a/b </italic></sup>
Sl2/2 McCa/b genotype is associated with decreased susceptibility to cerebral malaria
###end title 35
###begin p 36
###xml 206 215 206 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl1/1 McC</italic>
###xml 215 219 215 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a/a </italic>
###xml 215 219 215 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a/a </italic></sup>
###xml 248 249 248 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 281 288 281 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl/McC </italic>
###xml 398 407 398 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl1/2 McC</italic>
###xml 407 411 407 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a/b </italic>
###xml 407 411 407 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a/b </italic></sup>
###xml 498 507 498 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl1/1 McC</italic>
###xml 507 510 507 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a/b</italic>
###xml 507 510 507 510 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a/b</italic></sup>
###xml 512 521 512 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl1/1 McC</italic>
###xml 521 525 521 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b/b </italic>
###xml 521 525 521 525 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b/b </italic></sup>
###xml 529 538 529 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl1/2 McC</italic>
###xml 538 542 538 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b/b </italic>
###xml 538 542 538 542 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b/b </italic></sup>
###xml 648 649 648 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 694 697 694 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">McC</italic>
###xml 697 701 697 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a/a </italic>
###xml 697 701 697 701 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a/a </italic></sup>
###xml 757 763 757 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl1/2 </italic>
###xml 766 771 766 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl2/2</italic>
###xml 853 862 853 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl2/2 McC</italic>
###xml 862 866 862 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a/b </italic>
###xml 862 866 862 866 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a/b </italic></sup>
###xml 975 979 975 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl2 </italic>
###xml 983 986 983 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink">McC</italic>
###xml 986 988 986 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b </italic>
###xml 986 988 986 988 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b </italic></sup>
In order to determine the effect of the different genotype combinations at the Swain-Langley and McCoy loci on the susceptibility to severe malaria conditional logistic regression was carried out using the Sl1/1 McCa/a genotype as reference (Table 4). Only six of the ten possible Sl/McC genotype combinations were found. Although it is not known whether the haplotypes for the group with genotype Sl1/2 McCa/b are 1a/2b or 1b/2a, it was assumed that these individuals were 1a/2b because genotypes Sl1/1 McCa/b, Sl1/1 McCb/b and Sl1/2 McCb/b were not found in the population, suggesting that haplotype 1b is extremely rare or does not exist. Table 4 shows that among CM cases and controls with McCa/a background the susceptibility to CM (OR) decreased from Sl1/2 to Sl2/2, suggesting a gene dose effect. The strongest association was seen with genotype Sl2/2 McCa/b (OR = 0.18, 95% CI = 0.04 to 0.77, P = 0.02). Interestingly, heterozygosity at both loci or homozygozity for Sl2 and McCb did not show any significant benefit.
###end p 36
###begin p 37
###xml 93 102 93 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl1/1 McC</italic>
###xml 102 105 102 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a/a</italic>
###xml 102 105 102 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a/a</italic></sup>
Conditional logistic regression to compare genotype combinations to the non-African genotype Sl1/1 McCa/a.
###end p 37
###begin p 38
OR = Odds Ratio, CI = Confidence Interval, Ref = Reference category
###end p 38
###begin title 39
Discussion
###end title 39
###begin p 40
###xml 54 60 54 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl2/2 </italic>
###xml 173 179 173 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl1/1 </italic>
###xml 255 259 255 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">McC </italic>
###xml 429 432 429 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">McC</italic>
###xml 432 436 432 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a/a </italic>
###xml 432 436 432 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a/a </italic></sup>
###xml 441 447 441 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl1/2 </italic>
###xml 450 455 450 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl2/2</italic>
###xml 598 604 598 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl2/2 </italic>
###xml 689 692 689 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink">McC</italic>
###xml 692 694 692 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b </italic>
###xml 692 694 692 694 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b </italic></sup>
###xml 708 709 708 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
The present study has shown that individuals with the Sl2/2 genotype that confers the Sl -1,2 phenotype have decreased susceptibility to CM compared to individuals with the Sl1/1 genotype. This finding was independent of ethnicity, of the genotype at the McC locus and of the hospital site where the cases and controls were recruited. Among the combined genotypes, a trend of increasing benefit was observed in the background of McCa/a from Sl1/2 to Sl2/2, which is consistent with a gene dose effect. Although the level of statistical significance may be influenced by a larger sample size in the Sl2/2 category, the association nevertheless appears strongest with the acquisition of one McCb allele (Table 4).
###end p 40
###begin p 41
###xml 26 35 26 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl2/2 McC</italic>
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a/b </italic>
###xml 35 39 35 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a/b </italic></sup>
###xml 152 153 152 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 153 157 153 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink"> McC</italic>
###xml 157 161 157 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a/b </italic>
###xml 157 161 157 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a/b </italic></sup>
###xml 268 271 268 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">McC</italic>
###xml 271 274 271 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a/a</italic>
###xml 271 274 271 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a/a</italic></sup>
###xml 310 311 310 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 335 338 335 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">McC</italic>
###xml 338 342 338 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a/a </italic>
###xml 338 342 338 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a/a </italic></sup>
###xml 367 376 367 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl1/1 McC</italic>
###xml 376 379 376 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a/a</italic>
###xml 376 379 376 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a/a</italic></sup>
###xml 381 390 381 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl1/2 McC</italic>
###xml 390 393 390 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a/a</italic>
###xml 390 393 390 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a/a</italic></sup>
###xml 399 408 399 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl2/2 McC</italic>
###xml 408 412 408 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a/a </italic>
###xml 408 412 408 412 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a/a </italic></sup>
###xml 508 512 508 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl2 </italic>
###xml 519 520 519 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 560 566 560 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl2/2 </italic>
The finding that genotype Sl2/2 McCa/b might be the one that most influences the level of susceptibility to CM may seem counterintuitive since in Table 3 McCa/b did not show any significant advantage and perhaps showed a trend towards a detrimental effect relative to McCa/a. However, in the analysis in Table 3 the reference genotype McCa/a contains three variants: Sl1/1 McCa/a, Sl1/2 McCa/a, and Sl2/2 McCa/a with the latter two both showing indications of decreased susceptibility due to the presence of Sl2 (Table 4). The lack of significant benefit from Sl2/2 in SMA probably reflects the distinct pathogenic mechanisms between this condition and CM, but this does not exclude a role for CR1 in the pathogenesis of SMA.
###end p 41
###begin p 42
###xml 72 74 72 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 134 140 134 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl2/2 </italic>
###xml 457 465 <span type="species:ncbi:9606">children</span>
In contrast to this study, a previous case-control study in The Gambia [20] failed to demonstrate any significant association between Sl2/2 and resistance to severe malaria. The divergence in findings between the present and the previous study could be explained by important methodological differences. In the Gambian study controls did not have malaria. This may have led to an overrepresentation of non-protective genotypes in the controls because these children did not have the most important risk factor for severe malaria, i.e. malaria. Further, cases and controls were not matched by age in the Gambian study, and in fact, cases were older than controls by an average of almost one year. In addition, it is possible that differences in the pathogenesis of severe malaria between the two sites on the basis of other genetic factors and/or differences in the malaria transmission patterns may exist.
###end p 42
###begin p 43
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl2 </italic>
###xml 35 38 35 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">McC</italic>
###xml 38 40 38 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b </italic>
###xml 38 40 38 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b </italic></sup>
###xml 421 425 421 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl2 </italic>
###xml 573 576 573 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">McC</italic>
###xml 576 578 576 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b </italic>
###xml 576 578 576 578 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b </italic></sup>
###xml 717 719 717 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1050 1051 1050 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1232 1234 1232 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1643 1647 1643 1647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl2 </italic>
###xml 1651 1654 1651 1654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">McC</italic>
###xml 1654 1655 1654 1655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 1654 1655 1654 1655 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b</italic></sup>
The mechanism by which the Sl2 and McCb alleles could confer protection from severe malaria is not known, since these polymorphisms are located near the C-terminus of the CR1 molecule in an area that is outside the binding sites for C3b, C4b, and PfEMP-1. Nonetheless, there are a number of potential explanations based on the knowledge of CR1 function and the nature of the amino acid substitutions that take place. The Sl2 allele is the result of the substitution of glycine, a neutral amino acid, for the basic amino acid arginine at position 1601 (R1601G), whereas the McCb allele is the result of the substitution of the acidic amino acid glutamic acid for the basic amino acid lysine at position 1590 (K1590E) [17]. These modifications may inflict significant conformational or charge changes to the rest of the molecule and may consequently impact on the conformation and function of the C3b and C4b binding sites and/or the PfEMP-1 binding site. Accordingly, Sl -1,2 erythrocytes have been reported to rosette less than Sl 1,-2 erythrocytes [3]. In addition, it is known that CR1 molecules are aggregated on the erythrocyte surface and this aggregation is felt to be critical to the binding affinity of CR1 for C3b and C4b [25]. Therefore, it is possible that the amino acid substitutions not only induce conformational changes to the individual CR1 molecules but also affect the ability of functional aggregates to form due to conformational incompatibility or charge interference between different CR1 molecules. This could explain why some combinations of these alleles, such as heterozygosity at both loci or homozygosity for both Sl2 and McCb, did not offer any significant advantage.
###end p 43
###begin p 44
###xml 568 570 568 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 640 642 640 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 573 577 <span type="species:ncbi:10090|species:ncbi:10095">Mice</span>
Although the current expectation is that CR1 may influence the development of severe malaria by virtue of its function as a regulator of the complement cascade on RBCs or by its direct interaction with the infected RBCs leading to rosette formation, CR1 may exert its effect on malaria in other ways that are not yet understood. In addition to being present on RBCs, CR1 is also present on follicular dendritic cells, macrophages and T and B lymphocytes and, therefore, may also have immunoregulatory functions that affect the development of immunity against malaria [13]. Mice deficient in CR1/CR2 have depressed humoral immune responses [26]. Further studies will be required to explore this possibility.
###end p 44
###begin p 45
###xml 312 314 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
Further evidence that the role of CR1 in the pathogenesis of severe malaria may not be as expected is found in a recent case-control study in Papua New Guinea that aimed to determine whether there was an association between individuals who had the low CR1 expression allele (L) and resistance to severe malaria [27]. Contrary to expectation, the association was found only in heterozygotes (HL), and not in homozygotes (LL), which presumably had the lowest CR1 levels. In addition, although there was an association with resistance to severe malaria as a whole, there was no apparent association between these polymorphisms and CM. These results suggest that the relationship between the number of CR1 molecules on the RBC surface and severe malaria is not a straightforward one.
###end p 45
###begin p 46
The results obtained in the study presented here have biological significance and are further supportive evidence of the importance of CR1 in the pathogenesis of severe malaria. Whatever the mechanism is by which CR1 is involved in the pathogenesis of malaria, knowledge of which alleles are associated with resistance or susceptibility to severe malaria will make it possible to observe the relationship between structure and function and susceptibility to severe malaria.
###end p 46
###begin title 47
Conclusion
###end title 47
###begin p 48
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sl2 </italic>
###xml 74 77 74 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">McC</italic>
###xml 77 79 77 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b </italic>
###xml 77 79 77 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b </italic></sup>
The results support the conclusion that the Sl2 allele and, possibly, the McCb allele have evolved in the context of malaria transmission in Africa and that in certain combinations probably confer a survival advantage to malaria endemic populations.
###end p 48
###begin title 49
Authors' contributions
###end title 49
###begin p 50
###xml 265 277 <span type="species:ncbi:9606">participants</span>
Vandana Thathy, assisted by Bernard Guyah, optimized and carried out the PCR, performed the restriction enzyme digestions and interpreted the RFLP results. JoAnn M. Moulds developed the PCR-RFLP assay. Walter Otieno supervised the clinical evaluations of the study participants. Jose A. Stoute was the principal investigator who designed the study, wrote the protocol and drafted the original manuscript that was reviewed and edited by all authors.
###end p 50
###begin title 51
Acknowledgements
###end title 51
###begin p 52
###xml 27 35 <span type="species:ncbi:9606">children</span>
We would like to thank the children who participated in our studies as well as their parents for their willingness to contribute to this research endeavor. We are indebted to our dedicated staff of clinicians, nurses, drivers and field workers who made these studies possible. We are also grateful to Dr. John Rowlands for statistical support and for reviewing the paper. This work is published with the permission of the Office of the Director, the Kenya Medical Research Institute.
###end p 52
###begin p 53
This work was supported in part by the US Army Medical Research and Materiel Command, by grants from the National Heart Lung and Blood Institute (RO1 HL 7502-01) to Jose A. Stoute and from the National Institute of Allergy and Infectious Diseases (RO1 AI 42367) to Joann M. Moulds. Vandana Thathy was supported by a fellowship from the Ellison Medical Foundation and the National Research Council. Bernard Guyah and Walter Otieno were supported by a training grant from the Fogarty International Center (1 D43 TW06239-01). Funding agencies had no role in the design of the study, the data collection, data analysis, data interpretation, writing of the manuscript, nor in the decision to submit the manuscript for publication.
###end p 53
###begin p 54
"The views of the authors do not purport to reflect the position of the Department of the Army or the Department of Defense. The U.S. Government has the right to retain a nonexclusive, royalty-free license in and to any copyright covering this paper."
###end p 54
###begin article-title 55
Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster
###end article-title 55
###begin article-title 56
###xml 0 13 <span type="species:ncbi:5833">P. falciparum</span>
P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1
###end article-title 56
###begin article-title 57
###xml 65 86 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Mapping of the region of complement receptor (CR) 1 required for Plasmodium falciparum rosetting and demonstration of the importance of CR1 in rosetting in field isolates
###end article-title 57
###begin article-title 58
###xml 52 60 <span type="species:ncbi:9606">children</span>
###xml 73 94 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Red cell surface changes and erythrophagocytosis in children with severe Plasmodium falciparum anemia
###end article-title 58
###begin article-title 59
Loss of red blood cell complement regulatory proteins and increased levels of circulating immune complexes are associated with severe malarial anemia
###end article-title 59
###begin article-title 60
Age-related changes in red blood cell complement regulatory proteins and the susceptibility to severe malaria
###end article-title 60
###begin article-title 61
Structure-function relationships of complement receptor type 1
###end article-title 61
###begin article-title 62
Complement receptor 1/CD35 is a receptor for mannan-binding lectin
###end article-title 62
###begin article-title 63
Complement receptor type 1 (CR1, CD35) is a receptor for C1q
###end article-title 63
###begin article-title 64
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies
###end article-title 64
###begin article-title 65
###xml 0 21 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Plasmodium falciparum rosetting is associated with malaria severity in Kenya
###end article-title 65
###begin article-title 66
Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21).
###end article-title 66
###begin article-title 67
Analysis of complement receptor type 1 (CR1) expression on erythrocytes and of CR1 allelic markers in Caucasian and African American populations
###end article-title 67
###begin article-title 68
Erythrocyte CR1 expression level does not correlate with a HindIII restriction fragment length polymorphism in Africans; implications for studies on malaria susceptibility
###end article-title 68
###begin article-title 69
The C3b/C4b receptor is recognized by the Knops, McCoy, Swain-langley, and York blood group antisera
###end article-title 69
###begin article-title 70
Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1
###end article-title 70
###begin article-title 71
###xml 18 23 <span type="species:ncbi:9606">human</span>
Identification of human erythrocyte blood group antigens on the C3b/C4b receptor
###end article-title 71
###begin article-title 72
International Society of Blood Transfusion Committee on terminology for red cell surface antigens: Vancouver Report
###end article-title 72
###begin article-title 73
CR1 Knops blood group alleles are not associated with severe malaria in the Gambia
###end article-title 73
###begin article-title 74
Malaria transmission and morbidity
###end article-title 74
###begin article-title 75
###xml 109 117 <span type="species:ncbi:9606">children</span>
Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children
###end article-title 75
###begin article-title 76
Sampling and storage of blood and the detection of malaria parasites by polymerase chain reaction
###end article-title 76
###begin article-title 77
Identification of the Kna/Knb polymorphism and a method for Knops genotyping
###end article-title 77
###begin article-title 78
Difference in the clustering of complement receptor type 1 (CR1) on polymorphonuclear leukocytes and erythrocytes: effect on immune adherence
###end article-title 78
###begin article-title 79
###xml 45 49 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2
###end article-title 79
###begin article-title 80
###xml 2 7 <span type="species:ncbi:9606">human</span>
###xml 56 77 <span type="species:ncbi:5833">Plasmodium falciparum</span>
A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria
###end article-title 80

